Futility in clinical research
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Gonzalo Romero
Overview
During the conduction of a clinical trial several interim analysis are performed in order to obtain data that could be used for early termination of the trial or adjusting the study's protocol due to futility, adverse effects profiles or insignificant statistical efficacy of the intervention being studied. This data is reported to the Data Monitoring Committee (DMC) which can help in decision making of the trial.